GJC3 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-87499
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Format
BSA Free
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of human GJC3. Peptide sequence: WHWELSGKGKEEETLIQGREGNTDVPGAGSLRLLWAYVAQLGARLVLEGAA The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Description
Novus Biologicals Rabbit GJC3 Antibody - BSA Free (NBP2-87499) is a polyclonal antibody validated for use in WB. All Novus Biologicals antibodies are covered by our 100% guarantee.
Scientific Data Images for GJC3 Antibody - BSA Free
Western Blot: GJC3 Antibody [NBP2-87499]
Western Blot: GJC3 Antibody [NBP2-87499] - WB Suggested Anti-GJC3 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: PANC1 cell lysateApplications for GJC3 Antibody - BSA Free
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Format
BSA Free
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: GJC3
Alternate Names
connexin 29, Connexin-30.2, Connexin-31.3, CX29, Cx30.2, CX30.2connexin-31.3, CX31.3, Gap junction epsilon-1 protein, gap junction gamma-3 protein, gap junction protein, epsilon 1, 29kDa, gap junction protein, gamma 3, 30.2kDa, GJE1
Gene Symbol
GJC3
Additional GJC3 Products
Product Specific Notices for GJC3 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...